BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27349173)

  • 1. In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.
    Li S; Wu L; Feng J; Li J; Liu T; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Kong R; Chen K; Wang F; Xia Y; Lu J; Zhou Y; Dai W; Guo C
    Sci Rep; 2016 Jun; 6():28479. PubMed ID: 27349173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
    Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C
    Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
    Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
    J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation.
    Kaufmann R; Henklein P; Henklein P; Settmacher U
    Oncol Rep; 2009 May; 21(5):1261-7. PubMed ID: 19360302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
    Huang W; Ding L; Huang Q; Hu H; Liu S; Yang X; Hu X; Dang Y; Shen S; Li J; Ji X; Jiang S; Liu JO; Yu L
    Hepatology; 2010 Aug; 52(2):703-14. PubMed ID: 20683966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
    Shen X; Zhang Y; Feng Y; Zhang L; Li J; Xie YA; Luo X
    Int J Oncol; 2014 Mar; 44(3):791-6. PubMed ID: 24402647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
    Yang H; Wang M; Sun H; Zhu S; Jin J
    Pharmacology; 2019; 104(5-6):267-275. PubMed ID: 31434088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
    Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
    J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals.
    Abou El Naga RN; Azab SS; El-Demerdash E; Shaarawy S; El-Merzabani M; Ammar el-SM
    Life Sci; 2013 Mar; 92(10):555-61. PubMed ID: 23352978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
    Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
    Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study.
    Sabry D; Abdelaleem OO; El Amin Ali AM; Mohammed RA; Abdel-Hameed ND; Hassouna A; Khalifa WA
    Mol Biol Rep; 2019 Apr; 46(2):2039-2047. PubMed ID: 30710234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.
    Farhan M; Rizvi A; Naseem I; Hadi SM; Ahmad A
    Tumour Biol; 2015 Nov; 36(11):8861-7. PubMed ID: 26069106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
    Tsang WP; Kwok TT
    J Nutr Biochem; 2010 Feb; 21(2):140-6. PubMed ID: 19269153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
    Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
    Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
    Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS
    Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.